UnivLabs Technologies Pvt Ltd

Key People

• Sunil Singh - Founder & CEO
  Email: sunil@univlabs.in
• Dr. Anil Mandhani - Co-Founder
• Amitbir Singh Banga - Director

Assessment

Team

Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with a strong background in medical technology and entrepreneurship.

Sunil Singh, the Founder & CEO, has a proven track record in the MedTech industry. Co-Founder Dr. Anil Mandhani brings valuable medical expertise, enhancing the company's ability to develop clinically relevant products. Director Amitbir Singh Banga adds strategic leadership, contributing to the company's robust growth trajectory.

Clinical Need

Aspect: Very Strong
Summary: UnivLabs addresses critical gaps in affordable and innovative medical devices, particularly in endoscopy and diabetic care.

The development of the world's first 4K cloud-connected endoscope tower and a wearable insulin patch pump demonstrates UnivLabs' commitment to addressing pressing clinical needs. These innovations offer enhanced diagnostic capabilities and improved patient management, particularly in resource-constrained settings.

Competition

Aspect: Somewhat crowded
Summary: The medical device market is competitive, with several established players; however, UnivLabs' focus on affordability and innovation provides a competitive edge.

Major competitors include companies like KARL STORZ, Becton, Dickinson and Company, Olympus, and Stryker. UnivLabs' emphasis on cost-effective solutions and cutting-edge technology positions it favorably in the market, despite the presence of these established firms.

Technical Challenge

Aspect: Moderate
Summary: Developing advanced medical devices involves moderate technical challenges, which UnivLabs has successfully navigated.

The creation of complex devices like the 4K endoscope tower and insulin patch pump requires significant technical expertise. UnivLabs' successful product development indicates a strong technical foundation, though ongoing innovation will be necessary to maintain competitiveness.

Patent

Aspect: Strong
Summary: With eleven applied patents and two granted, UnivLabs has a solid intellectual property portfolio.

The granted patents, including one for the world's smallest syringe-based insulin patch pump, underscore UnivLabs' commitment to innovation and its ability to secure intellectual property rights, enhancing its market position.

Financing

Aspect: Medium
Summary: UnivLabs has raised 39.5 crore across five funding rounds, indicating moderate financial backing.

The most recent Series A round closed in March 2025, with significant investment from Victora Group. While this funding has facilitated product development and market expansion, further investment may be necessary to achieve long-term objectives.

Regulatory

Aspect: 510k/PMA
Summary: UnivLabs maintains an ISO 13485 certified manufacturing setup, indicating compliance with international regulatory standards.

ISO 13485 certification demonstrates UnivLabs' commitment to quality management systems in medical device manufacturing. This compliance facilitates entry into global markets and builds trust with healthcare providers and patients.

Opportunity Rollup

Odds of Success

3.55

Peak Market Share

4.8

Segment CAGR

10.7%

Market Segment

Medical Devices

Market Sub Segment

Endoscopy Devices

Key Takeaway

UnivLabs Technologies Pvt Ltd, with its innovative and affordable medical devices, is well-positioned to capitalize on the growing demand for advanced endoscopic solutions, despite facing competition and regulatory challenges.